RNA Viruses, Pandemics and Anticipatory Preparedness
- PMID: 36298729
- PMCID: PMC9611157
- DOI: 10.3390/v14102176
RNA Viruses, Pandemics and Anticipatory Preparedness
Abstract
RNA viruses are likely to cause future pandemics and therefore we must create and organize a deep knowledge of these viruses to prevent and manage this risk. Assuming prevention will fail, at least once, we must be prepared to manage a future pandemic using all resources available. We emphasize the importance of having safe vaccine candidates and safe broad-spectrum antivirals ready for rapid clinical translation. Additionally, we must have similar tools to be ready for outbreaks of RNA viruses among animals and plants. Finally, similar coordination should be accomplished for other pathogens with pandemic potential.
Keywords: RNA viruses; anticipatory preparedness; pandemics.
Conflict of interest statement
M.A.G-B. declares that he is the scientific cofounder and has a significant ownership stake in Emervax Inc. (Galveston, TX), which is commercializing vaccines for highly pathogenic RNA viruses with high pandemic potential.
Figures
References
-
- CDC Health and Economic Costs of Chronic Diseases. [(accessed on 25 September 2022)]; Available online: https://www.cdc.gov/chronicdisease/about/costs/index.htm.
-
- Jackson J., Weiss M.A., Schwarzenberg A.B., Nelson R.M., Sutter K.M., Sutherland M.D. Global Economic Effects of COVID-19. Congressional Research Service; Washington, DC, USA: 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical